Nicotine Lozenge
Product Images NDC 82966-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 82966-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blip Products, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Nicotine Fig1)

This text appears to be a set of instructions for a quit-smoking program that involves taking lozenges at specific intervals. The program spans over a total of 12 weeks, with reminders to take the lozenges at specific times at the beginning of each week. The lozenges are to be taken every one to two hours during week 1, every two to four hours during week 2, and every four to eight hours during the third step. The final reminder is to be set at the beginning of week 10, 12 weeks after the quit date.*

FDA Label Image

Figure2 (Nicotine Fig2)

This is a wallet card that provides information on where to call for help for different health conditions. It includes contact numbers for the American Lung Association, American Cancer Society, American Heart Association, and the option to seek support from a quitting buddy or friend who has quit. The text also includes a reference number: P1524649.*

FDA Label Image

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Label))

The text describes a product or lot identified by a code and an expiration date. The label or printout of the code and expiration date information occurs during the packing process. The product or lot is identified as "UNVARNISH ZONE".*

FDA Label Image

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Carton Label))

This is a list of inactive ingredients found in a drug identified as containing acesulfame potassium, artificial flavors, calcium, magnesium stearate, mannitol, sodium carboate anthan gum, among others. The listed ingredients are not to be sold to individuals under 18 years of age, and proof of age is required. The product is made in India and may require a prescription. The user is advised to see a doctor in the event of certain symptoms. The use of more than one lozenge at a time is not recommended. In case of an overdose or allergic reaction, medical help should be sought immediately. Keep the container properly sealed and away from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.